A cardiac pacemaker is a small device that is implanted in the chest to help control the heartbeats. It is used for the treatment of slow heart beating. Implanting cardiac pacemaker in the chest requires a surgical procedure. There are various types of cardiac pacemaker such as single chamber pacemaker and dual-chamber pacemakers where single chamber pacemaker is used as one lead placed within the lower chamber, or ventricle, of the heart. Cardiac pacemakers are used to treat bradycardia and atrial fibrillation associated with bradycardia. Bradycardia is an abnormally slow heartbeat defined by 60 or less beats per minute. Dual-chamber pacemakers have two leads, placed in the right atrium and right ventricle. They act synchronously when a slow natural heart rate is detected to mimic the sequential physiological contraction of the atria and ventricles. There are two ways followed for implanting pacemakers such as implantable pacemaker and external pacemakers, where in implantable pacemaker, which is a device that implanted (internally) within the body for providing electrical impulses to regulate the heart rhythm or to reproduce that rhythm. External pacemakers is implanted outside the body, which is electrodes based medical device used for maintaining heart rate.
Market Dynamics
Increasing product approvals by regulatory authorities for cardiac pacemaker is expected to drive the global cardiac pacemaker market over the forecast period. For instance, on April 4, 2022, Abbott, a medical device manufacturer announced that the U.S. Food and Drug Administration (FDA) s approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients with sluggish cardiac rhythms. Moreover, to treat slower-than-normal heart rates, Aveir leadless pacemaker is placed directly inside the right ventricle of the heart via a minimally invasive surgery. The gadget has a unique mapping function that allows doctors to analyze electrical signals within the heart and identify the device's proper placement before it is implanted.
Key features of the study:
- This report provides an in-depth analysis of the global cardiac pacemaker market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac pacemaker market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, Abbott, BIOTRONIK SE & Co. KG, Pacetronix , Lepu Medical Technology(Beijing)Co., Ltd. , LIVANOVA PLC, MEDICO S.R.L., OSCOR Inc., MicroPort Scientific Corporation, OSYPKA MEDICAL, and Vitatron Holding B.V.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cardiac pacemaker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global cardiac pacemaker market
Detailed Segmentation:
- Global Cardiac Pacemaker Market, by Product Type:
- Single-chamber Pacemaker
- Dual-chamber Pacemaker
- Biventricular Pacemaker
- Global Cardiac Pacemaker Market, by Implantability:
- Implantable Pacemakers
- External Pacemakers
- Global Cardiac Pacemaker Market, by End User:
- Hospitals
- Cardiac Clinics
- Ambulatory Surgical Centers
- Global Cardiac Pacemaker Market, By Region:
- North America
- By Product Type:
- Single-chamber Pacemaker
- Dual-chamber Pacemaker
- Biventricular Pacemaker
- By Implantability:
- Implantable Pacemakers
- External Pacemakers
- By End User:
- Hospitals
- Cardiac Clinics
- Ambulatory Surgical Centers
- By Country:
- Latin America
- By Product Type:
- Single-chamber Pacemaker
- Dual-chamber Pacemaker
- Biventricular Pacemaker
- By Implantability:
- Implantable Pacemakers
- External Pacemakers
- By End User:
- Hospitals
- Cardiac Clinics
- Ambulatory Surgical Centers
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Single-chamber Pacemaker
- Dual-chamber Pacemaker
- Biventricular Pacemaker
- By Implantability:
- Implantable Pacemakers
- External Pacemakers
- By End User:
- Hospitals
- Cardiac Clinics
- Ambulatory Surgical Centers
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Single-chamber Pacemaker
- Dual-chamber Pacemaker
- Biventricular Pacemaker
- By Implantability:
- Implantable Pacemakers
- External Pacemakers
- By End User:
- Hospitals
- Cardiac Clinics
- Ambulatory Surgical Centers
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Single-chamber Pacemaker
- Dual-chamber Pacemaker
- Biventricular Pacemaker
- By Implantability:
- Implantable Pacemakers
- External Pacemakers
- By End User:
- Hospitals
- Cardiac Clinics
- Ambulatory Surgical Centers
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Single-chamber Pacemaker
- Dual-chamber Pacemaker
- Biventricular Pacemaker
- By Implantability:
- Implantable Pacemakers
- External Pacemakers
- By End User:
- Hospitals
- Cardiac Clinics
- Ambulatory Surgical Centers
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Medtronic *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Abbott
- BIOTRONIK SE & Co. KG
- Pacetronix
- Lepu Medical Technology (Beijing) Co., Ltd.
- LIVANOVA PLC
- MEDICO S.R.L.
- OSCOR Inc.
- MicroPort Scientific Corporation,
- OSYPKA MEDICAL
- Vitatron Holding B.V.
“*” marked represents similar segmentation in other categories in the respective section.
